Global Amifostine Market Professional Survey Report 2018 - 2025

Description

This report studies the global Amifostine market status and forecast, categorizes the global Amifostine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol.
Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.

Consumption of amifostine mainly concentrates in North America. In 2016, the region consumed 780 K Unit, holding about 52% market share globally. The follower is Asia-Pacific, with about 41% consumption share.

The market is relatively concentrated and there are just a few suppliers in the market, such as Clinigen Group, Sun Pharmaceutical, Merro Pharmaceutical and so on. Clinigen Group acquired the business from AstraZeneca in the year of 2014 and signed an agreement with Cumberland in the year of 2016. Under the agreement, Cumberland acquired the exclusive rights to commercialize Ethyol in the United States. Merro Pharmaceutical own the largest sales share in China.

Amifostine shows good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment. It is estimated that the amifostine market will keep upward tendency and to be worthy of 49.99 million USD in 2023 globally.

The global Amifostine market is valued at 48 million US$ in 2017 and will reach 57 million US$ by the end of 2025, growing at a CAGR of 2.2% during 2018-2025.

The major manufacturers covered in this report
Clinigen Group
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
...

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
400mg/Dose
500mg/Dose

By Application, the market can be split into
Head and Neck Cancer Adjuvant Therapy
Others

The study objectives of this report are:
To analyze and study the global Amifostine capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Amifostine manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Amifostine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Amifostine Manufacturers
Amifostine Distributors/Traders/Wholesalers
Amifostine Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, We offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Amifostine market, by end-use.
Detailed analysis and profiles of additional market players.

TABLE OF CONTENT

Table of Contents

Global Amifostine Market Professional Survey Report 2018
1 Industry Overview of Amifostine
1.1 Definition and Specifications of Amifostine
1.1.1 Definition of Amifostine
1.1.2 Specifications of Amifostine
1.2 Classification of Amifostine
1.2.1 400mg/Dose
1.2.2 500mg/Dose
1.3 Applications of Amifostine
1.3.1 Head and Neck Cancer Adjuvant Therapy
1.3.2 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India

2 Manufacturing Cost Structure Analysis of Amifostine
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Amifostine
2.3 Manufacturing Process Analysis of Amifostine
2.4 Industry Chain Structure of Amifostine

3 Technical Data and Manufacturing Plants Analysis of Amifostine
3.1 Capacity and Commercial Production Date of Global Amifostine Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Amifostine Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Amifostine Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Amifostine Major Manufacturers in 2017

4 Global Amifostine Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Amifostine Capacity and Growth Rate Analysis
4.2.2 2017 Amifostine Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Amifostine Sales and Growth Rate Analysis
4.3.2 2017 Amifostine Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Amifostine Sales Price
4.4.2 2017 Amifostine Sales Price Analysis (Company Segment)

5 Amifostine Regional Market Analysis
5.1 North America Amifostine Market Analysis
5.1.1 North America Amifostine Market Overview
5.1.2 North America 2013-2018E Amifostine Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Amifostine Sales Price Analysis
5.1.4 North America 2017 Amifostine Market Share Analysis
5.2 Europe Amifostine Market Analysis
5.2.1 Europe Amifostine Market Overview
5.2.2 Europe 2013-2018E Amifostine Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E Amifostine Sales Price Analysis
5.2.4 Europe 2017 Amifostine Market Share Analysis
5.3 China Amifostine Market Analysis
5.3.1 China Amifostine Market Overview
5.3.2 China 2013-2018E Amifostine Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E Amifostine Sales Price Analysis
5.3.4 China 2017 Amifostine Market Share Analysis
5.4 Japan Amifostine Market Analysis
5.4.1 Japan Amifostine Market Overview
5.4.2 Japan 2013-2018E Amifostine Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E Amifostine Sales Price Analysis
5.4.4 Japan 2017 Amifostine Market Share Analysis
5.5 Southeast Asia Amifostine Market Analysis
5.5.1 Southeast Asia Amifostine Market Overview
5.5.2 Southeast Asia 2013-2018E Amifostine Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E Amifostine Sales Price Analysis
5.5.4 Southeast Asia 2017 Amifostine Market Share Analysis
5.6 India Amifostine Market Analysis
5.6.1 India Amifostine Market Overview
5.6.2 India 2013-2018E Amifostine Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Amifostine Sales Price Analysis
5.6.4 India 2017 Amifostine Market Share Analysis

6 Global 2013-2018E Amifostine Segment Market Analysis (by Type)
6.1 Global 2013-2018E Amifostine Sales by Type
6.2 Different Types of Amifostine Product Interview Price Analysis
6.3 Different Types of Amifostine Product Driving Factors Analysis
6.3.1 400mg/Dose Growth Driving Factor Analysis
6.3.2 500mg/Dose Growth Driving Factor Analysis

7 Global 2013-2018E Amifostine Segment Market Analysis (by Application)
7.1 Global 2013-2018E Amifostine Consumption by Application
7.2 Different Application of Amifostine Product Interview Price Analysis
7.3 Different Application of Amifostine Product Driving Factors Analysis
7.3.1 Head and Neck Cancer Adjuvant Therapy of Amifostine Growth Driving Factor Analysis
7.3.2 Others of Amifostine Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Amifostine
8.1 Clinigen Group
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Clinigen Group 2017 Amifostine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Clinigen Group 2017 Amifostine Business Region Distribution Analysis
8.2 Sun Pharmaceutical
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Sun Pharmaceutical 2017 Amifostine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Sun Pharmaceutical 2017 Amifostine Business Region Distribution Analysis
8.3 Taj Pharmaceuticals
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Taj Pharmaceuticals 2017 Amifostine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Taj Pharmaceuticals 2017 Amifostine Business Region Distribution Analysis
8.4 Merro Pharmaceutical
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Merro Pharmaceutical 2017 Amifostine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Merro Pharmaceutical 2017 Amifostine Business Region Distribution Analysis
8.5 Luye Pharma
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Luye Pharma 2017 Amifostine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Luye Pharma 2017 Amifostine Business Region Distribution Analysis
8.6 Mingren Pharma
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Mingren Pharma 2017 Amifostine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Mingren Pharma 2017 Amifostine Business Region Distribution Analysis

9 Development Trend of Analysis of Amifostine Market
9.1 Global Amifostine Market Trend Analysis
9.1.1 Global 2018-2025 Amifostine Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Amifostine Sales Price Forecast
9.2 Amifostine Regional Market Trend
9.2.1 North America 2018-2025 Amifostine Consumption Forecast
9.2.2 Europe 2018-2025 Amifostine Consumption Forecast
9.2.3 China 2018-2025 Amifostine Consumption Forecast
9.2.4 Japan 2018-2025 Amifostine Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Amifostine Consumption Forecast
9.2.6 India 2018-2025 Amifostine Consumption Forecast
9.3 Amifostine Market Trend (Product Type)
9.4 Amifostine Market Trend (Application)

10 Amifostine Marketing Type Analysis
10.1 Amifostine Regional Marketing Type Analysis
10.2 Amifostine International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Amifostine by Region
10.4 Amifostine Supply Chain Analysis

11 Consumers Analysis of Amifostine
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Amifostine Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source

Choose License Type

Checkout Inquiry